THE TAPE
$191.40▼ −1.67%
Last close
Relative strength
88RS
of 99, against every stock▲ +22 on the month
Powering up
Unconfirmed
+67.9%
six months against the S&P 500
52-week range
−12.6%
from the high
$66.57$219.04
Setup
On no screen
No base, flag or squeeze in place tonight. What is and is not there
No report date on the calendar.
Growth FLATProof PENDING
Quarter to Sep 30, revenue −3% on a year ago
Why it is on no screen

ICLR is off the screens on one check: a base has formed.

A base has formedNo pause of 3 weeks or more inside the last 24 weeks.
Long enough to countNeeds a base first.
Shallow enoughNeeds a base first.
Close to its pivotNeeds a base first.
Relative strengthRS 88 against 70 needed.

Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.

Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
Support and resistance
Support below
$183.81
-4.0% · tested 3× · last 78 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

Icon Plc is not on any of the screens right now. Its relative strength rating is 88, and it sits in Commercial Physical & Biological Research.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
+16.0%
Three months against the S&P 500
+18.8%
Six months against the S&P 500
+67.9%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 11.8% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$8.2B
-2.9% year on year
Operating margin
8.7%
Net margin
5.4%
Free cash flow
$857.1M
5.8% of market cap
Price to sales
1.78×
Price to earnings
32.7×

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Oct 27
Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$2.0B
-1.9% QoQ · -2.9% YoY
Gross margin
—
Net income
$122.1M
Positive
Free cash flow
$307.1M
Cash generating

What the numbers say

  • Revenue -2.9% year over year, -1.9% on the quarter
  • Good: Profitable: net income $122M, operating margin 9.8%
  • Good: Cash generating: operating cash flow $345M, free cash flow $307M
  • Net debt $2.57B · cash $809M
Revenue by quarter
Free cash flow
Net income
shares 0.0% in a year · net debt $2.6B

What is not obvious

  • Weak: Cash flow quality: operating cash flow $345M included a $128M deferred-revenue inflow; $217M without it. Customers paid ahead of delivery
  • Weak: Debt $3.38B, +60% on the quarter; 0.4× trailing revenue
  • Contracted backlog (remaining performance obligations) $16.40B, 2.0× trailing revenue, +4% on the quarter. Backlog is not recognised revenue

The desk’s own read

Flagged as drifting up since the report

Final read
Growth: FLAT · Economic proof: PENDING
Key question: Does the cash flow hold without the deferred revenue and stock pay behind it?
The next test is whether the quarter repeats.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

None of the tracked funds held or sold it in their latest filings.

Flagged by the market sweep
Tightening after a sharp runTape · 2026-11-05
range halved after a +27% thrust, at 203.11
No measurable effect: stocks behave like random ones over the next three sessions (887 cases over 60 nights).
New 52-week highTape · 2026-10-29
4.1x vol
Mixed: stocks have lagged random stocks by 0.9% over three sessions, not consistently enough to call (554 cases over 52 nights). Against their own sector they have lagged by 2.1%.
Closed above its 20- and 50-day on heavy volumeTape · 2026-10-29
above 20d & 50d on 4.1x volume at 214.16
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
GappedTape · 2026-10-29
+17.0%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ up on earningsTape · 2026-10-29
+17.0% on earnings 2026-10-27
No measurable effect: stocks behave like random ones over the next three sessions (604 cases over 42 nights).
Unusual volumeTape · 2026-10-29
12.9 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Earnings comingEvent · 2026-10-27
reports 2026-10-27 amc
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).
GappedTape · 2026-10-22
+6.3%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
58
$6,228,527 total

Sold: Balfe Barry Edward, Lyons Emer, Clerkin Nigel Bernard John, Murray Ciaran, McCague Eugene Pacelli, Murphy Ronan Martin, CLIMAX JOHN DR, Whitaker Anne Clem, O'Neill Julie, Grais Linda.

Not counted above: 17 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-11-02 Balfe Barry Edward · Chief Executive Officer, Directorsell1,053$215,770
2026-11-02 Balfe Barry Edward · Chief Executive Officer, Directorsell1,509$311,080
2026-11-02 Balfe Barry Edward · Chief Executive Officer, Directorsell1,224$253,564
2026-11-02 Balfe Barry Edward · Chief Executive Officer, Directorsell1,314$273,312
2026-11-02 Balfe Barry Edward · Chief Executive Officer, Directorsell75$15,715
2026-11-02 Lyons Emer · Chief Accounting Officersell54$11,065
2026-11-02 Lyons Emer · Chief Accounting Officersell76$15,667
2026-11-02 Lyons Emer · Chief Accounting Officersell63$13,051

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What analysts expect
Strong buy1
Buy9
Hold7
Sell0
Strong sell1

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

No completed base to compare this one with yet.

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Icon Plc (ICLR) — The Tape